Preoperative tumor markers at diagnosis in women with malignant mixed müllerian tumors/carcinosarcoma of the uterus.
CA125 is a well-recognized marker for endometrial cancer. Uterine malignant mixed müllerian tumors (MMMTs) are increasingly being recognized as an aggressive adenocarcinoma, not a sarcoma. There are no data in the literature regarding CA125 in this malignancy. One hundred twelve women with surgically staged MMMT, diagnosed between July 1990 and September 2005, had a retrospective chart review performed. Preoperative CA125 levels were available in 29 (26%) women. Seventeen (49%) women had levels above the upper limit of normal of 35 kmicro/L. Mean levels increased with increasing surgical stage: stage I 53.4 kmicro/L; stage II 122.5 kmicro/L; stage III 147.1 kmicro/L; and stage IV 428.4 kmicro/L. Elevated levels of CA19-9, CEA, and CA15-3 were found in 8%, 12%, and 25%, respectively.
Hoskins
P J
PJ
Division of Medical Oncology and Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia, Canada. phoskins@bccancer.bc.ca
Le
N
N
D014408:Biomarkers, Tumor / Q000097:blood*; D002296:Carcinosarcoma / Q000097:blood* / Q000175:diagnosis* / Q000601:surgery; D005260:Female; D006801:Humans; D018200:Mixed Tumor, Mullerian / Q000097:blood* / Q000175:diagnosis* / Q000601:surgery; D009367:Neoplasm Staging; D014594:Uterine Neoplasms / Q000097:blood* / Q000175:diagnosis* / Q000601:surgery
D014408:Biomarkers, Tumor